Session date: 
Friday, May 1, 2015 - 8:00am to 9:00am
Location: 
Froedtert Hospital
9200 W Wisconsin Avenue
Dean Roe Auditorium
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

Weekly grand rounds as a forum for clinical and basic research updates in neurology with respect to diagnosis and management of neurological disorders and advances in neuroscience.  General areas of focus will include among others the following:  neuromuscular, epilepsy, sleep, movement disorders, stroke and vascular disorders, neurodegenertive, dementia and memory disorders, headaches and cranial neuralgias, autonomic disorders, and general neurologic conditions.

Accreditation Statement
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Designation of Credit Statement
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
Target audience: 

Neurologists and Neuropsychologists as a specialty, including both generalists and sub-specialists.  Health care providers including physicians (MD's, DO's) RN, APNP, PA,  PhD, as well as students, residents, and fellows.  Also included are basic and clinical researchers and clinicians throughout neurology, neurosurgery, and neuropsychology especially during the monthly interdisciplinary grand rounds presentations.

Learning objectives: 

Learning Objectives:

1.  Understand how stem cells may be used to treat some of the symptoms of degenerative diseases such as ALS, HD and Parkinson’s 

2.  Learn how induced pluripotent stem cells from patients with neurological disease may be used to generate novel models and screen neurologically relevant drugs

3.  Learn how an idea moved from the bench side, through pre clinical studies and into a clinical trial to treat ALS

    Faculty & credentials: 

    Planning Committee:

    Jonathan Florczak, MD
    Assistant Professor
    Department of Neurology
     
    David Sabsevitz, PhD, ABPP
    Boart Certified in Clinical Neuropsychology
    Assistant Professor of Neurology
    Director of Postdoctoral Education
    Medical College of Wisconsin
    Presenters Name:
    Clive Svendsen, PhD
    Professor and Director
    Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine
    Board of Governors Regenerative Medicine Institute
    Cedars-Sinai Medical Center
    Los Angeles, California
     

    CME Coordinator Contact Information

    Name: 
    Julie Williamson
    Phone number: 
    +1 (414) 805-5206